Remanufacturing Guide Tops FDA’s 2023 Device Guidance Agenda

By Beth Wang / November 3, 2022 at 2:56 PM

FDA’s remanufacturing draft guidance is at the top of the device center’s guidance agenda for fiscal 2023, indicating the agency could publish the highly-anticipated final version of the document this fiscal year.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.